367 related articles for article (PubMed ID: 28401454)
1. Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes.
Haak T; Hanaire H; Ajjan R; Hermanns N; Riveline JP; Rayman G
Diabetes Ther; 2017 Jun; 8(3):573-586. PubMed ID: 28401454
[TBL] [Abstract][Full Text] [Related]
2. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.
Haak T; Hanaire H; Ajjan R; Hermanns N; Riveline JP; Rayman G
Diabetes Ther; 2017 Feb; 8(1):55-73. PubMed ID: 28000140
[TBL] [Abstract][Full Text] [Related]
3. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
[TBL] [Abstract][Full Text] [Related]
4. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R
Lancet; 2016 Nov; 388(10057):2254-2263. PubMed ID: 27634581
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study.
Campbell FM; Murphy NP; Stewart C; Biester T; Kordonouri O
Pediatr Diabetes; 2018 Nov; 19(7):1294-1301. PubMed ID: 30054967
[TBL] [Abstract][Full Text] [Related]
6. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
[TBL] [Abstract][Full Text] [Related]
7. Effect of the FreeStyle Libre™ flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: An open label, prospective, multicenter trial in Japan.
Ogawa W; Hirota Y; Osonoi T; Tosaki T; Kato Y; Utsunomiya K; Nishimura R; Nakamura J
J Diabetes Investig; 2021 Jan; 12(1):82-90. PubMed ID: 32562376
[TBL] [Abstract][Full Text] [Related]
8. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
[TBL] [Abstract][Full Text] [Related]
9. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
[TBL] [Abstract][Full Text] [Related]
10. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.
Wada E; Onoue T; Kobayashi T; Handa T; Hayase A; Ito M; Furukawa M; Okuji T; Okada N; Iwama S; Sugiyama M; Tsunekawa T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Kuwatsuka Y; Ando M; Goto M; Arima H
BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32518063
[TBL] [Abstract][Full Text] [Related]
11. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes.
Scott EM; Bilous RW; Kautzky-Willer A
Diabetes Technol Ther; 2018 Mar; 20(3):180-188. PubMed ID: 29470094
[TBL] [Abstract][Full Text] [Related]
12. A review of flash glucose monitoring in type 2 diabetes.
Krakauer M; Botero JF; Lavalle-González FJ; Proietti A; Barbieri DE
Diabetol Metab Syndr; 2021 Apr; 13(1):42. PubMed ID: 33836819
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
[TBL] [Abstract][Full Text] [Related]
14. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
Garg S; Zisser H; Schwartz S; Bailey T; Kaplan R; Ellis S; Jovanovic L
Diabetes Care; 2006 Jan; 29(1):44-50. PubMed ID: 16373894
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.
Castellana M; Parisi C; Di Molfetta S; Di Gioia L; Natalicchio A; Perrini S; Cignarelli A; Laviola L; Giorgino F
BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32487593
[TBL] [Abstract][Full Text] [Related]
16. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
Malanda UL; Welschen LM; Riphagen II; Dekker JM; Nijpels G; Bot SD
Cochrane Database Syst Rev; 2012 Jan; 1():CD005060. PubMed ID: 22258959
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of the FreeStyle Libre
Jendle J; Eeg-Olofsson K; Svensson AM; Franzen S; Lamotte M; Levrat-Guillen F
Diabetes Ther; 2021 Dec; 12(12):3137-3152. PubMed ID: 34694584
[TBL] [Abstract][Full Text] [Related]
18. Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol.
Musolino G; Allen JM; Hartnell S; Wilinska ME; Tauschmann M; Boughton C; Campbell F; Denvir L; Trevelyan N; Wadwa P; DiMeglio L; Buckingham BA; Weinzimer S; Acerini CL; Hood K; Fox S; Kollman C; Sibayan J; Borgman S; Cheng P; Hovorka R
BMJ Open; 2019 Jun; 9(6):e027856. PubMed ID: 31164368
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
